** Australia-listed shares of a2 Milk A2M.AX down 0.7% at A$8.47
** Citi says food tech firm Clover's strong 1H25 results suggests positive near-term outlook for infant formula sector
** Clover, an infant formula ingredient supplier, logs HY net profit after tax A$2.4 million ($1.53 million) vs loss A$0.6 mln last year
** Citi flags recovery of infant formula business in Europe and ANZ in Clover's results
** A2's execution has been strong in recent years when the birth rate was declining and domestic brands were taking share; both of those headwinds have now turned to tailwinds - Citi
** Citi also expects new market gains for a2 Milk as co accelerates new product development
** Brokerage maintains "Buy" rating and price target A$8.2
** Stock up 46.5% YTD, including current session's moves
($1 = 1.5723 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。